Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer
- PMID: 1571915
- DOI: 10.1002/1097-0142(19920601)69:11<2842::aid-cncr2820691133>3.0.co;2-c
Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer
Abstract
Seven hundred fifty-nine patients with Stage I/II breast cancer who were treated with mastectomy alone (558 patients) or breast-conserving surgery and tangential irradiation (201 patients) were evaluated. Median follow-up time was 34 months. Axillary node status showed differences between treatment groups. Seventy-two percent of patients undergoing lumpectomy and radiation therapy (Lx) versus 35% of patients in the mastectomy group were pathologically node-negative, 18% Lx versus 30% mastectomy alone had one to three nodes positive, and four or more positive axillary nodes were seen in 35% of mastectomy alone patients. Reflecting this trend, overall survival (P less than 0.007), time to locoregional failure (P less than 0.0005), and time to any failure (P less than 0.0001) favored Lx patients. Correcting for axillary node status, significant differences persisted only for node-negative patients. Median actuarial survival time was 73 months for the mastectomy alone group (196 patients) versus 120 months for the Lx group (144 patients) (P less than 0.02), with significant differences also noted in time to local failure (P less than 0.003) and time to any failure (P less than 0.001). Stratification according to primary tumor size in patients who were node-negative yielded marked differences in time to locoregional failure in T1 (less than 2 cm) (P less than 0.0006) presentations, with analysis approaching significance for T2 (2 to 5 cm) lesions (P less than 0.06). Disease-free interval was greater in node-negative Lx patients for both T1 (P less than 0.007) and T2 (P less than 0.05) presentations. Overall survival was not significantly different in node-negative Lx patients when primary tumor size was considered. Improved prognosis was identified in node-negative patients undergoing breast-conserving surgery and radiation therapy over mastectomy alone. Theoretical considerations included eradication of occult microscopic disease within the chest wall by tangential irradiation.
Similar articles
-
Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):541-50. doi: 10.1016/s0360-3016(97)00001-1. Int J Radiat Oncol Biol Phys. 1997. PMID: 9231678
-
Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):551-9. doi: 10.1016/s0360-3016(97)89483-7. Int J Radiat Oncol Biol Phys. 1997. PMID: 9231679
-
Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1062-73. doi: 10.1016/j.ijrobp.2003.12.034. Int J Radiat Oncol Biol Phys. 2004. PMID: 15234040
-
Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes.Int J Radiat Oncol Biol Phys. 1997 Nov 1;39(4):915-20. doi: 10.1016/s0360-3016(97)00456-2. Int J Radiat Oncol Biol Phys. 1997. PMID: 9369141 Review.
-
Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.Cancer. 1999 Apr 15;85(8):1773-81. Cancer. 1999. PMID: 10223572 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical